Target intelligence / Profile preview

Gamma-aminobutyric acid type A receptor alpha-3 beta-2 gamma-2 (GABA_A receptor α3β2γ2) (GABA_A receptor α3β2γ2)

Target
GABA_A receptor α3β2γ2
Molecular classification
Ligand-gated ion channel, Cys-loop receptor, Chloride channel, Receptor
01

Overview

The Gamma-aminobutyric acid type A (GABA_A) receptor alpha-3 beta-2 gamma-2 is a heteropentameric ligand-gated ion channel that serves as a primary mediator of fast inhibitory neurotransmission in the central nervous system [1, 2]. It is composed of two alpha-3, two beta-2, and one gamma-2 subunits, forming a central pore permeable to chloride and bicarbonate ions [4, 9]. Upon binding of the endogenous neurotransmitter GABA, the channel opens, leading to hyperpolarization of the postsynaptic neuron and a decrease in its excitability [6, 7]. This specific subtype is notably expressed in the reticular nucleus of the thalamus, the spinal cord dorsal horn, and the basal ganglia, playing a critical role in sensory processing, muscle tone, and anxiety regulation [9, 31]. Pharmacologically, it is a target for benzodiazepines and other allosteric modulators, which enhance the receptor's response to GABA [12, 15]. Research into alpha-3-selective modulators aims to develop treatments for chronic pain and anxiety that lack the sedative side effects typically associated with alpha-1-containing GABA_A receptors [25, 32]. Dysregulation or mutations in the subunits of this receptor are linked to conditions such as epilepsy, autism, and chronic pain syndromes [8, 11, 32].

Other names
GABRA3/GABRB2/GABRG2 receptorα3β2γ2 GABA-A receptorGamma-aminobutyric acid receptor subunit alpha-3/beta-2/gamma-2 complexGABRA3-GABRB2-GABRG2
02

Mechanism of action

Positive allosteric modulation of the GABA-A receptor chloride channel, increasing chloride ion conductance and causing neuronal hyperpolarization.

03

Biological functions

Inhibitory neurotransmissionPhasic inhibitionRegulation of neuronal excitabilityMuscle relaxationAnxiolysisAnalgesia
04

Disease associations

AnxietyChronic painEpilepsySleep disordersAutism spectrum disorderNeurodevelopmental disorders
05

Safety considerations

SedationCognitive impairmentMotor impairmentToleranceDependenceWithdrawal symptomsRespiratory depressionSelectivity challenges
06

Interacting drugs

Diazepam

14 more in the full profile.

07

Biomarkers

Electroencephalography (EEG) theta power[11C]flumazenil positron emission tomography (PET) imaging

Beyond the preview

Go deeper on Gamma-aminobutyric acid type A receptor alpha-3 beta-2 gamma-2 (GABA_A receptor α3β2γ2) (GABA_A receptor α3β2γ2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha-3 beta-2 gamma-2 (GABA_A receptor α3β2γ2) (GABA_A receptor α3β2γ2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call